Dr. Reddy's Laboratories Limited (RDY)
NYSE: RDY · Real-Time Price · USD
14.25
-0.13 (-0.90%)
Mar 3, 2026, 4:00 PM EST - Market closed

Dr. Reddy's Laboratories Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
11,7601,010,3371,124,567871,181851,801936,819
Market Cap Growth
0.78%-10.16%29.09%2.27%-9.07%52.12%
Enterprise Value
11,635-312,367-4,587,724-7,301,9272,798,984596,177
Last Close Price
14.2513.1914.6711.3911.1512.28
PE Ratio
18.6716.6318.3117.2829.8743.36
Forward PE
22.88-----
PS Ratio
3.060.030.040.040.040.05
PB Ratio
2.810.030.040.040.050.06
P/TBV Ratio
--0.040.040.050.06
P/FCF Ratio
29.520.580.420.200.690.39
P/OCF Ratio
16.740.240.270.160.330.29
EV/Sales Ratio
3.02-0.01-0.18-0.320.140.03
EV/EBITDA Ratio
12.33-0.04-0.64-1.240.790.18
EV/EBIT Ratio
15.73-0.05-0.78-1.551.140.28
EV/FCF Ratio
29.20-0.18-1.72-1.672.260.25
Debt / Equity Ratio
0.180.120.070.050.190.18
Debt / EBITDA Ratio
2.320.470.250.200.930.85
Debt / FCF Ratio
1.852.090.670.272.681.19
Net Debt / Equity Ratio
-0.04-0.06-0.22-0.400.11-0.02
Net Debt / EBITDA Ratio
-0.51-0.22-0.79-1.390.55-0.10
Net Debt / FCF Ratio
-0.40-0.97-2.14-1.871.57-0.14
Asset Turnover
0.660.740.770.780.770.76
Inventory Turnover
2.242.102.092.061.861.88
Quick Ratio
1.171.141.681.750.760.96
Current Ratio
1.881.922.572.611.931.78
Return on Equity (ROE)
16.10%18.53%20.95%20.55%13.07%10.51%
Return on Assets (ROA)
1.50%11.43%13.50%12.06%6.99%6.11%
Return on Invested Capital (ROIC)
1.90%14.91%20.14%16.42%8.49%7.65%
Return on Capital Employed (ROCE)
2.58%20.64%23.21%22.54%14.03%13.64%
Earnings Yield
5.36%6.01%5.46%5.79%3.35%2.31%
FCF Yield
3.39%172.44%237.66%502.52%145.35%255.14%
Dividend Yield
0.50%0.00%0.65%0.68%0.59%0.56%
Payout Ratio
9.46%11.78%11.94%11.71%18.13%24.75%
Buyback Yield / Dilution
0.03%10.90%-6.59%-3.91%-3.61%9.08%
Total Shareholder Return
0.54%10.90%-5.94%-3.23%-3.02%9.64%
Updated Jan 21, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q